| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...989770M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0089770 |
| P932 | PMC publication ID | 3935931 |
| P698 | PubMed publication ID | 24587024 |
| P5875 | ResearchGate publication ID | 260448108 |
| P50 | author | Jordan Warford | Q39051134 |
| P2093 | author name string | David W Hoskin | |
| Carolyn D Doucette | |||
| Alexander S Easton | |||
| Suzanne J Furlong | |||
| Carolyn J MacMillan | |||
| P2860 | cites work | Angiogenesis is regulated by angiopoietins during experimental autoimmune encephalomyelitis and is indirectly related to vascular permeability. | Q54550069 |
| Decreased Expression of VEGF-A in Rat Experimental Autoimmune Encephalomyelitis and in Cerebrospinal Fluid Mononuclear Cells from Patients with Multiple Sclerosis | Q61964009 | ||
| The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3 | Q73101597 | ||
| Multiple forms of angiostatin induce apoptosis in endothelial cells | Q77655144 | ||
| Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells | Q77754337 | ||
| VEGF and vascular changes in chronic neuroinflammation | Q79304449 | ||
| Angiostatin binds ATP synthase on the surface of human endothelial cells | Q22009028 | ||
| Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation | Q24290939 | ||
| Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells | Q24319640 | ||
| Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin | Q24601633 | ||
| Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer | Q29622818 | ||
| Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. | Q30454412 | ||
| Interaction between bevacizumab and murine VEGF-A: a reassessment | Q30840642 | ||
| Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. | Q33226862 | ||
| Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis | Q34095225 | ||
| Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions | Q34499810 | ||
| Antiangiogenic cancer therapy | Q35690275 | ||
| Lymphatic drainage of the brain and the pathophysiology of neurological disease | Q37323411 | ||
| Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest | Q37407741 | ||
| Anti-angiogenic therapy: concept to clinic | Q37955304 | ||
| Cardiovascular toxicity of anti-angiogenic drugs | Q37960873 | ||
| Modulation of blood-brain barrier permeability by neutrophils: in vitro and in vivo studies | Q39803965 | ||
| Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses | Q44916496 | ||
| VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. | Q46114183 | ||
| A mathematical model for vasogenic brain edema | Q46782511 | ||
| Novel technique for estimating cerebrovascular permeability demonstrates capsazepine protection following ischemia-reperfusion. | Q46973570 | ||
| Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties | Q48087236 | ||
| Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study | Q48183763 | ||
| Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter | Q48366860 | ||
| Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats | Q48465059 | ||
| Two components of blood-brain barrier disruption in the rat. | Q48615890 | ||
| Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University | Q48699723 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| angiogenesis inhibitor | Q574834 | ||
| P304 | page(s) | e89770 | |
| P577 | publication date | 2014-02-26 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors B20-4.1.1 and angiostatin (K1-3) | |
| P478 | volume | 9 |
| Q34109028 | Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. |
| Q91838110 | Aryl hydrocarbon receptor nuclear translocator-like (ARNTL/BMAL1) is associated with bevacizumab resistance in colorectal cancer via regulation of vascular endothelial growth factor A |
| Q34620249 | The role of angiogenesis in the pathology of multiple sclerosis |
Search more.